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Abstract: Calcified coronary lesions are challenging to deal with, as they require optimal lesion preparation. Direct stenting in this 
scenario is associated with risk of stent-underexpansion, which is related to in-stent restenosis, target lesion revascularization and 
stent-thrombosis. We report on the interventional management of an underexpanded bare-metal stent not amenable to high-pressure 
balloon dilation and cutting-balloon. By using rotablation we could abrade the underexpanded stent struts and the calcification with 
subsequent implantation of a drug-eluting stent. Follow-up of 6 months revealed good results without evidence of significant resteno-
sis. Our clinical experience and case reports in the literature suggest that this strategy might be an option for underexpanded stents not 
amenable to conventional techniques.
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Introduction
Direct  coronary  stent  implantation  is  an  elegant 
technique  for  coronary  artery  revascularization.1 
However, calcified coronary lesions, often seen in 
older patients suffering from diabetes mellitus, renal 
failure  and  hypertension,  are  challenging  to  deal 
with, as they require optimal lesion preparation prior 
stenting for avoiding stent underexpansion which is 
related to in-stent restenosis, target lesion revascu-
larization and subsequent stent   thrombosis.2 Several 
strategies  and  technologies  have  been  developed 
to address the problem of heavily calcified coro-
nary lesions. These include simple dilatation using 
  standard non-compliant balloon, cutting balloon and 
plaque modification using rotational atherectomy. 
We report on the management of an underexpanded 
bare-metal stent in a patient with heavily   calcified 
lesion not amenable to   high-pressure balloon-dilata-
tion. Written consent was ontained from the patient.
case
A 72-year old man suffering from progressive angina 
over the past 8 weeks presented to our chest pain unit. 
He  had  previously  documented  insulin-  dependent 
diabetes,  alimentary  obesity,  hyperlipidemia  and 
arterial  hypertension.  An  ambulatory  performed 
myocardial  perfusion  scintigraphy  revealed  a 
reduced  tracer-uptake  in  the  apex,  left  posterior 
and antero-lateral wall during physical examination 
(100  watt-cycling).  Coronary    angiography,  which 
was performed via right radial access using a 5F 
sheath, revealed a 50% stenosis of the left anterior 
descending artery (LAD) and ramus posterolatera-
lis sinistra (RPLS) while the right coronary artery 
(RCA) had a critical 90% stenosis (Fig. 1A). Due 
to  the  patients’  symptoms  and  the  angiographic 
  findings  we  decided  to    perform  a    percutaneous 
  coronary  intervention  (PCI). The  patient  received 
600  mg  clopidogrel,  500  mg  aspirin  and  5000U 
heparin   followed by primary PCI and direct stent-
ing  of  a  bare-metal  stent  (BMS)  (Coroflex  blue 
3.5  mm/8  mm,  B.  Braun,  Melsungen,  Germany) 
with 18 atm for 30 sec (Fig. 1B). Post-PCI angiog-
raphy revealed a 75% stenosis in the mid-portion of 
the stent (Fig. 1C). A subsequent dilatation with a 
semi-compliant  balloon  (Pantera  3,5/10  mm  with 
[Biotronik, Berlin, Germany] 18 atm over 30 sec), a 
non-compliant balloon (Quantum 3,5/8 mm [Boston 
Scientific, Natick, USA] with 20 atm over 30 sec) 
and a cutting-balloon (3,0/10 mm [Boston Scientific, 
Natick, USA] with 18 atm over 30 sec) could not 
expand the stent further; pointing out the heavily 
calcified nature of this lesion. Due to the fact that an 
underexpanded stent is a predictor for worse clinical 
outcome we decided on rotablation. We puncture the 
right brachial artery and introduced an 8F sheath. 
Additionally we introduced a 5F sheath in right fem-
oral vein and inserted a transient pacemaker lead. 
After  passing  across  the  stenosis  with  the  0.009 
rotawire we ablade the heavily calcified stenosis as 
well as the stent struts (stentablation) (Fig. 2A). All 
ablations were performed with a 1.75 mm burr with at 
least 150,000 rpm and ablation times ,30 sec with-
out a decrease in rotational speed of .5,000 rpm. 
The procedure was free of complications and we 
continued with dilatation with a non-compliant bal-
loon (Quantum 3,5/8 mm with 20 atm over 30 sec) 
and a cutting-balloon (3,0/10 mm with 16 atm over 
30 sec). With complete expansion of the balloons 
the procedure was continued with implantation of a 
drug-eluting stent (Taxus Liberté 4.0/12 mm [Boston 
Scientific, Natick, USA] with 16 atm over 30 sec) 
(rotastenting) (Fig. 2B). Finally, there was TIMI 3 
without evidence of dissection or residual stenosis 
(Fig. 2C). Following uneventful hospital stay with-
out evidence of myocardial necrosis the patient was 
discharged after 3 days on 100 mg aspirin, 75 mg 
clopidogrel, 5 mg bisoprolol, 5 mg of ramipril and 
40 mg simvastatin with a recommendation for dual 
antiplatelet therapy of 1 year without any change 
in his extra-cardiovascular medications. A routine 
coronary  angiography  performed  6  months  after 
index-PCI revealed a good result with a mild (25%) 
restenosis (Fig. 2D).
Figure 1. Coronary angiography reveals a 90% stenosis of the right coro-
nary artery (rCA) (A). Direct stenting of the bare metal stent (BMS) results 
in an underexpansion (B) and residual stenosis in the mid-part (c).Stentablation and rotastenting in stent-underexpansion
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Discussion
Direct stenting is the implanation of stents in coronary 
lesions without predilatation.1 From animal restenosis 
models, direct stenting without the need for predila-
tation appears to reduce vessel trauma, in particular 
as a result of less endothelial denudation, resulting 
in less neointimal hyperplasia subsequently.1 PCI of 
calcified  and  complex  lesions  has  been  associated 
with lower success rates, an increased frequency of 
acute complications, and higher restenosis rates than 
PCI of simple lesions.2 As seen in our case, deliver-
ing the stent may be difficult and stent expansion may 
be inadequate in heavily calcified lesions, resulting in 
smaller acute gain compared to non-calcified lesions.2 
It is widely accepted that achieving postprocedural 
residual stenosis is a major determinant of resteno-
sis during follow-up and optimal stent expansion is a 
crucial factor in minimizing the risk of stent throm-
bosis pointed out by the fact that only 22% of patients 
that experienced subacute stent thrombosis have an 
acceptable PCI result as assessed by IVUS.2,3
A variety of strategies and technologies have been 
developed  to  address  the  problem  of  an  underex-
panded stent. The POSTIT trial revealed that in case 
of using only the stent delivery balloon over 70% 
of  patients  did  not  achieve  optimal  stent  deploy-
ment.4 Use of non-compliant balloon to achieve full 
distension  in  resitant  lesions  is  a  reasonable  first-
step.   However, focal points of resistance within a 
lesion result in non-uniform balloon expansion and 
characteristic  “dog-boning”  with  overexpansion  in 
the more compliant segments. In this non-uniform 
expansion  may  cause  vessel  dissection  and  rup-
ture acutely as well as restenosis due to deep-wall 
injury  in  the    follow-up.  Cutting-balloon,  designed 
to score the vessel longitudinally rather than caus-
ing   uncontrolled plaque disruption, have been used 
  successfully in the   treatment of undilatable lesions.5 
In our case, none of these techniques were successful 
in reducing the underexpansion, demonstrating the 
nature of the heavily calcification, which was not 
assumed  on  initial  fluoroscopy.  Thus,  despite  the 
existence of limited data,6 we decided to rotablade the 
remaining calcification and the underexpanded stent 
struts to avoid aforementioned complications. High-
speed rotational atherectomy preferentially cuts hard 
plaque,  increases  plaque  compliance  and  thereby 
renders the lesion more amenable to balloon dilata-
tion.7 The rotablator is able to ablate inelastic tissue 
selectively while maintaining the integrity of elastic 
tissue due to the principle of differential cutting. The 
abraded  plaque  is  pulverized  into  microparticles, 
which are 5–10 µm in diameter. These particles are 
small enough to pass through the coronary microcir-
culation and ultimately undergo phagocytosis in the 
liver, spleen, and lung.7
The procedure performed in our case was unevent-
ful  with  no  dissection,  slow-flow,  heamodynamic 
compromise or myocardial necrosis. We had applied 
a transient pacemaker via the right femoral vein to 
overcome  possible  conduction  disturbances  when 
handling in the right coronary artery.
Several observational studies have confirmed that 
rotational atherectomy prior to stent deployment in 
severely calcified lesions does facilitate stent delivery 
and expansion, but incidence of restenosis remains 
unsatisfactory  (23%)  when  BMS  are  used.8  There 
is limited information about rotational atherectomy 
followed  by  DES  implantation,  but  initial  results 
seem promising.9 A comparison of BMS (n = 84) and 
DES (n = 213) after rotablation with cardiac death 
and recurrent myocardial infarction being defined as 
primary endpoint and binary restenosis as secondary 
endpoint revealed lower rates for primary endpoint 
Figure 2. Rotational atherectomy of the remaining calcified stenosis within the stent and the underexpanded stent struts (stentablation) (A) with accept-
able result in the following angiography. Drug-eluting stent (DeS) implantation (rotastenting) (B) after rotational atheterctomy without any evidence for 
residual stenosis in final angiogram (c). Coronary angiography performed 6 months after index-pCI revealed a mild (25%–50%) restenosis (D).publish with Libertas Academica and 
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in DES group (2.3% versus 7.1%; P = 0.04) during a 
follow-up of 1300 days.10
Despite  our  procedural  success  and  good  mid-
term result, there are no data on long-term follow-up 
after stentablation and rotastening. Thus, it should be 
emphasized that a better lesion preparation is needed 
to avoid stent underexpansion in undilatable lesions.
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